Elantas Beck India Ltd (ELANTAS) — shareholding pattern, promoter holding, financials and share price
About Elantas Beck India Ltd (ELANTAS)
Elantas Beck India Ltd operates in the Specialty Chemicals industry, within the Chemicals sector. It trades on the NSE as ELANTAS and on the BSE under scrip code 500123. Its ISIN is INE280B01018.
ELANTAS Beck India Limited is engaged in manufacturing a wide range of specialty chemicals in the electrical insulation and construction industries. It is a part of ALTANA, an international specialty chemicals group. [1]
Elantas Beck India Limited specializes in manufacturing specialty chemicals, primarily for electrical insulation and construction industries, operating manufacturing plants in Pimpri and Ankleshwar.
The company has historically expanded its production capacities and diversified into various synthetic insulation products catering to sectors like defense, telecommunications, and heavy electricals.
Listed peers in Specialty Chemicals: Alkyl Amines Chemicals Ltd, Clean Science & Technology Ltd, Balaji Amines Ltd, Galaxy Surfactants Ltd, Archean Chemical Industries Ltd, Neogen Chemicals Ltd.
Valuation & Returns
10 Jul 2026At ₹9,621.7 a share on 10 Jul 2026, Elantas Beck India Ltd (ELANTAS) was valued at a price-to-earnings ratio of 52.25x against an industry P/E of 45.11x and a price-to-book of 7.57x on a book value of ₹1,271.75 per share as of Dec 2025. Solomo computes return on equity of 14.48% and return on capital employed of 19.37% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 52.25x
- Industry P/E
- 45.11x
- P/B
- 7.57x
- EPS (TTM)
- ₹184.16
- Book value / share
- ₹1,271.75
- ROE
- 14.48%
- ROCE
- 19.37%
- ROA
- 12.52%
- Debt / equity
- 0x
- Dividend yield
- 0.08%
- EBITDA margin
- 25.19%
- 52-week range
- ₹7,111 – ₹14,250
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Dec 2025In the year ended Dec 2025, Elantas Beck India Ltd (ELANTAS) reported revenue of ₹848 crore, net profit of ₹148 crore and earnings per share of ₹186.41. That compares with revenue of ₹749 crore and net profit of ₹140 crore in Dec 2024. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹222 crore and net profit ₹31 crore (standalone).
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 522 | 645 | 680 | 749 | 848 |
| Net profit (₹ cr) | 67 | 98 | 137 | 140 | 148 |
| EPS (₹) | 84.36 | 123.34 | 173.19 | 176.04 | 186.41 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 8.41% | 17.22% | 9.56% | 13.27% |
| Profit growth | 11.72% | 19.06% | 14.76% | 5.89% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 75% of Elantas Beck India Ltd (ELANTAS) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.05% and domestic institutional investors (DII) hold 12.28%. Market capitalisation was ₹7,628 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund 8.42%, Tata Mutual Fund - Tata Small Cap Fund 3.83%, Anmol Sekhri Consultants Private Limited 1.02%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 75% | - | 0.05% | 12.28% | 25% |
| Mar 2026 | 75% | - | 0.04% | 12.25% | 25% |
| Dec 2025 | 75% | - | 0.04% | 12.21% | 25% |
| Sep 2025 | 75% | - | 0.04% | 12.17% | 25% |
| Jun 2025 | 75% | - | 0.04% | 12.17% | 25% |
| Mar 2025 | 75% | - | 0.51% | 11.71% | 25% |
| Dec 2024 | 75% | - | 0.67% | 11.71% | 25% |
| Sep 2024 | 75% | - | 0.67% | 11.88% | 25% |